In Vivo and in Vitro Characteristics of Interleukin 6-transfected B16 Melanoma Cells

Cancer Research

Volumn 52, Issue 19, 1992, Pages 5412-5415

  Ershler, William B ^a,b,c,d  

^a Department of Medicine ^*  (United States)

^b Human Oncology   (United States)

^c Birmingham Atlanta VA Geriatric Research Education and Clinical Center (GRECC)   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FIBRONECTIN; INTERLEUKIN 6; LAMININ; VITRONECTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL REACTIVITY; CELL ADHESION; CONTROLLED STUDY; DNA TRANSFECTION; FEMALE; HISTOLOGY; INFLAMMATORY INFILTRATE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMAL; CELL ADHESION; CELL DIVISION; COMPARATIVE STUDY; FEMALE; INTERLEUKIN-6; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION;

EID: 0026705784     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hirano, T. The Biology of interleukin-6. In: T. Kishimoto (ed.) Interleukins: Molecular Biology and Immunology, Chem Immunol. Basel: S. Karger AG, 1992.
2. Kishimoto, T. Factors affecting B cell growth and differentiation. Annu. Rev. Immunol., 3: 133-157, 1985.
3. Lotz, M., Jirik, F., Kabouridis, R., Tsoukas, C., Hirano, T., Kishimoto, T., Carson, D. A. BSF-2/IL-6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med., 167: 1253-1258, 1988.
4. Lee, C., Biondi, A., Wang, X. H., Iscove, N. N., de Sousa, J., Aarden, L. A., Wong, G. G., Clark, S. C., Messner, H. A., and Minden, M. D. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood, 74:798-804, 1989.
5. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. Autocrine generation and requirement of BSF/2/IL-6 for human multiple myelomas. Nature (Lond.), 332: 83-85, 1988.
6. Nordan, R. P., and Potter, M. Macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science (Washington DC), 233: 566-569, 1986.
7. Serve, H., Steinhauser, G., Oberberg, D., Flegel, W. A., NorthofT, H., Berdel, W. E. Studies on the interaction between interleukin 6 and human malignant nonhematopoietic cell lines. Cancer Res., 51: 3862-3866, 1991.
8. Mule, J. J., McIntosh, J. K., Jablons, D. M., and Rosenberg, S. A. Antitumor activity of recombinant interleukin 6 in mice. J. Exp. Med., 77: 629-636, 1990.
9. Tomita, Y., Montague, P. M., and Hearing, V. J. Monoclonal antibody production to a B16 melanoma associated antigen. Int. J. Cancer, 35: 543-547, 1985.
10. Ershler, W. B., Tuck, D., Moore, A. L., Klopp, R. G., and Kramer, K. E. Immunologic enhancement of B16 melanoma growth. Cancer (Phila.), 61: 1792-1797, 1988.
11. Sun, W. H., Stebler, B., and Ershler, W. B. Initial description of a tumor enhancing activity (TEA) produced by murine splenocytes. Biochem. Bio-phys. Res. Commun., 179: 675-682, 1991.
12. Golumbek, P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L. M., Karasuyama, H., Baker, M., and Pardoll, D. M. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science (Washington DC), 254: 713-716, 1991.
13. Van Snick, J., Cayphas, S., Vink, A., Uyttenhove, C., Coulie, P. G., and Simpson, R. J. Purification and NH2-terminal amino acid sequence of a new T-cell-derived lymphokine with growth factor activity for B cell hybridomas. Proc. Natl. Acad. Sci. USA, 83:9679-9683, 1986.
14. Kreisle, R. A., and Ershler, W. B. Investigation of tumor angiogenesis in an intradermal mouse model: role of host-tumor interactions. J. Natl. Cancer Inst., 80: 849-854, 1988.
15. Albelda, S. M., and Buck, C. A. Integrin and other cell adhesion molecules. FASEB J., 4: 2868-2880, 1990.
16. Filippo, G. G., and Ruoslahti, E. Elevated levels of the a5bl fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell, 60: 849-859, 1990.